US Stock MarketDetailed Quotes

RAPT RAPT Therapeutics

Watchlist
  • 1.575
  • -0.005-0.32%
Trading Jan 2 14:18 ET
55.06MMarket Cap-0.57P/E (TTM)

RAPT Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
19.48%-17.62M
2.27%-28.15M
-45.60%-27.08M
-37.13%-97.05M
-21.47%-27.75M
-27.61%-21.88M
-89.59%-28.81M
-19.41%-18.6M
-15.97%-70.77M
-10.48%-22.85M
Net income from continuing operations
41.25%-18.43M
-9.43%-27.66M
-4.27%-30.52M
-39.31%-116.8M
-34.53%-30.88M
-47.73%-31.37M
-31.78%-25.28M
-43.01%-29.27M
-21.15%-83.84M
-28.01%-22.95M
Operating gains losses
----
----
----
-204.47%-655K
--0
--0
----
----
143.02%627K
-282.61%-88K
Depreciation and amortization
-8.62%297K
13.38%305K
5.02%314K
16.14%1.22M
28.17%323K
25.00%325K
-1.82%269K
14.56%299K
5.12%1.05M
9.09%252K
Other non cash items
0.17%584K
0.00%584K
0.00%584K
32.67%2.34M
22.18%584K
36.21%583K
37.09%584K
36.45%584K
--1.76M
--478K
Change In working capital
-170.23%-4.08M
6.84%-6.02M
-126.30%-1.88M
511.91%5.5M
65.98%-990K
1,745.71%5.81M
-6,423.23%-6.46M
424.87%7.13M
68.94%-1.34M
46.86%-2.91M
-Change in prepaid assets
725.00%1.02M
133.96%1.12M
-189.18%-437K
161.29%871K
89.55%-223K
-17.33%124K
633.33%480K
-24.85%490K
19.44%-1.42M
0.47%-2.13M
-Change in payables and accrued expense
-168.89%-4.39M
-2.85%-6.43M
-110.00%-728K
97.71%7.34M
73.00%-71K
847.70%6.38M
-543.51%-6.25M
284.82%7.28M
297.64%3.71M
89.95%-263K
-Change in other current liabilities
-3.49%-712K
-3.34%-712K
-12.15%-711K
-29.09%-2.71M
-35.41%-696K
-35.43%-688K
-29.51%-689K
-16.76%-634K
---2.1M
---514K
-Change in other working capital
----
----
----
----
----
----
----
----
55.96%-1.53M
--0
Cash from discontinued investing activities
Operating cash flow
19.48%-17.62M
2.27%-28.15M
-45.60%-27.08M
-37.13%-97.05M
-21.47%-27.75M
-27.61%-21.88M
-89.59%-28.81M
-19.41%-18.6M
-15.97%-70.77M
-10.48%-22.85M
Investing cash flow
Cash flow from continuing investing activities
-28.37%18.45M
-40.77%19.21M
-37.23%15.89M
328.91%104.13M
150.01%20.64M
246.31%25.75M
410.16%32.44M
6.17%25.31M
44.08%-45.49M
-159.69%-41.27M
Net PPE purchase and sale
74.24%-17K
100.43%1K
86.17%-105K
-33.14%-1.13M
-36.73%-67K
18.52%-66K
58.83%-233K
-409.40%-759K
-11.92%-845K
87.56%-49K
Net investment purchase and sale
-28.48%18.46M
-41.19%19.21M
-38.65%15.99M
335.77%105.26M
150.23%20.71M
247.36%25.82M
430.27%32.67M
8.68%26.07M
44.60%-44.65M
-165.98%-41.22M
Cash from discontinued investing activities
Investing cash flow
-28.37%18.45M
-40.77%19.21M
-37.23%15.89M
328.91%104.13M
150.01%20.64M
246.31%25.75M
410.16%32.44M
6.17%25.31M
44.08%-45.49M
-159.69%-41.27M
Financing cash flow
Cash flow from continuing financing activities
0
-8.60%701K
7,689.66%9.04M
-98.90%1.45M
-99.39%458K
-97.98%106K
-98.48%767K
-12.12%116K
-7.28%131.18M
12,438.94%75.36M
Net common stock issuance
--0
--0
--8.97M
--0
--0
--0
--0
--0
-6.94%129.79M
39,806.91%75.03M
Proceeds from stock option exercised by employees
--0
-8.60%701K
-42.24%67K
3.95%1.45M
37.13%458K
-61.03%106K
17.28%767K
-12.12%116K
-31.16%1.39M
-19.13%334K
Cash from discontinued financing activities
Financing cash flow
--0
-8.60%701K
7,689.66%9.04M
-98.90%1.45M
-99.39%458K
-97.98%106K
-98.48%767K
-12.12%116K
-7.28%131.18M
12,438.94%75.36M
Net cash flow
Beginning cash position
-26.09%37.08M
-0.99%45.32M
21.91%47.48M
62.09%38.95M
95.39%54.14M
-12.31%50.16M
41.18%45.77M
62.09%38.95M
-3.58%24.03M
-53.82%27.71M
Current changes in cash
-79.27%823K
-287.44%-8.24M
-131.68%-2.16M
-42.81%8.53M
-159.23%-6.66M
113.46%3.97M
-82.26%4.4M
-18.70%6.82M
1,774.41%14.92M
131.25%11.24M
End cash Position
-29.99%37.9M
-26.09%37.08M
-0.99%45.32M
21.91%47.48M
21.91%47.48M
95.39%54.14M
-12.31%50.16M
41.18%45.77M
62.09%38.95M
62.09%38.95M
Free cash flow
19.64%-17.64M
3.06%-28.15M
-40.43%-27.19M
-37.08%-98.17M
-21.50%-27.82M
-27.39%-21.95M
-84.26%-29.04M
-23.11%-19.36M
-15.92%-71.62M
-8.65%-22.9M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024 (Q2)Jun 30, 2024 (Q1)Mar 31, 2024 (FY)Dec 31, 2023 (Q4)Dec 31, 2023 (Q3)Sep 30, 2023 (Q2)Jun 30, 2023 (Q1)Mar 31, 2023 (FY)Dec 31, 2022 (Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 19.48%-17.62M 2.27%-28.15M -45.60%-27.08M -37.13%-97.05M -21.47%-27.75M -27.61%-21.88M -89.59%-28.81M -19.41%-18.6M -15.97%-70.77M -10.48%-22.85M
Net income from continuing operations 41.25%-18.43M -9.43%-27.66M -4.27%-30.52M -39.31%-116.8M -34.53%-30.88M -47.73%-31.37M -31.78%-25.28M -43.01%-29.27M -21.15%-83.84M -28.01%-22.95M
Operating gains losses ---- ---- ---- -204.47%-655K --0 --0 ---- ---- 143.02%627K -282.61%-88K
Depreciation and amortization -8.62%297K 13.38%305K 5.02%314K 16.14%1.22M 28.17%323K 25.00%325K -1.82%269K 14.56%299K 5.12%1.05M 9.09%252K
Other non cash items 0.17%584K 0.00%584K 0.00%584K 32.67%2.34M 22.18%584K 36.21%583K 37.09%584K 36.45%584K --1.76M --478K
Change In working capital -170.23%-4.08M 6.84%-6.02M -126.30%-1.88M 511.91%5.5M 65.98%-990K 1,745.71%5.81M -6,423.23%-6.46M 424.87%7.13M 68.94%-1.34M 46.86%-2.91M
-Change in prepaid assets 725.00%1.02M 133.96%1.12M -189.18%-437K 161.29%871K 89.55%-223K -17.33%124K 633.33%480K -24.85%490K 19.44%-1.42M 0.47%-2.13M
-Change in payables and accrued expense -168.89%-4.39M -2.85%-6.43M -110.00%-728K 97.71%7.34M 73.00%-71K 847.70%6.38M -543.51%-6.25M 284.82%7.28M 297.64%3.71M 89.95%-263K
-Change in other current liabilities -3.49%-712K -3.34%-712K -12.15%-711K -29.09%-2.71M -35.41%-696K -35.43%-688K -29.51%-689K -16.76%-634K ---2.1M ---514K
-Change in other working capital ---- ---- ---- ---- ---- ---- ---- ---- 55.96%-1.53M --0
Cash from discontinued investing activities
Operating cash flow 19.48%-17.62M 2.27%-28.15M -45.60%-27.08M -37.13%-97.05M -21.47%-27.75M -27.61%-21.88M -89.59%-28.81M -19.41%-18.6M -15.97%-70.77M -10.48%-22.85M
Investing cash flow
Cash flow from continuing investing activities -28.37%18.45M -40.77%19.21M -37.23%15.89M 328.91%104.13M 150.01%20.64M 246.31%25.75M 410.16%32.44M 6.17%25.31M 44.08%-45.49M -159.69%-41.27M
Net PPE purchase and sale 74.24%-17K 100.43%1K 86.17%-105K -33.14%-1.13M -36.73%-67K 18.52%-66K 58.83%-233K -409.40%-759K -11.92%-845K 87.56%-49K
Net investment purchase and sale -28.48%18.46M -41.19%19.21M -38.65%15.99M 335.77%105.26M 150.23%20.71M 247.36%25.82M 430.27%32.67M 8.68%26.07M 44.60%-44.65M -165.98%-41.22M
Cash from discontinued investing activities
Investing cash flow -28.37%18.45M -40.77%19.21M -37.23%15.89M 328.91%104.13M 150.01%20.64M 246.31%25.75M 410.16%32.44M 6.17%25.31M 44.08%-45.49M -159.69%-41.27M
Financing cash flow
Cash flow from continuing financing activities 0 -8.60%701K 7,689.66%9.04M -98.90%1.45M -99.39%458K -97.98%106K -98.48%767K -12.12%116K -7.28%131.18M 12,438.94%75.36M
Net common stock issuance --0 --0 --8.97M --0 --0 --0 --0 --0 -6.94%129.79M 39,806.91%75.03M
Proceeds from stock option exercised by employees --0 -8.60%701K -42.24%67K 3.95%1.45M 37.13%458K -61.03%106K 17.28%767K -12.12%116K -31.16%1.39M -19.13%334K
Cash from discontinued financing activities
Financing cash flow --0 -8.60%701K 7,689.66%9.04M -98.90%1.45M -99.39%458K -97.98%106K -98.48%767K -12.12%116K -7.28%131.18M 12,438.94%75.36M
Net cash flow
Beginning cash position -26.09%37.08M -0.99%45.32M 21.91%47.48M 62.09%38.95M 95.39%54.14M -12.31%50.16M 41.18%45.77M 62.09%38.95M -3.58%24.03M -53.82%27.71M
Current changes in cash -79.27%823K -287.44%-8.24M -131.68%-2.16M -42.81%8.53M -159.23%-6.66M 113.46%3.97M -82.26%4.4M -18.70%6.82M 1,774.41%14.92M 131.25%11.24M
End cash Position -29.99%37.9M -26.09%37.08M -0.99%45.32M 21.91%47.48M 21.91%47.48M 95.39%54.14M -12.31%50.16M 41.18%45.77M 62.09%38.95M 62.09%38.95M
Free cash flow 19.64%-17.64M 3.06%-28.15M -40.43%-27.19M -37.08%-98.17M -21.50%-27.82M -27.39%-21.95M -84.26%-29.04M -23.11%-19.36M -15.92%-71.62M -8.65%-22.9M
Currency Unit USD USD USD USD USD USD USD USD USD USD
Accounting Standards US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP
Audit Opinions -- -- -- Unqualified Opinion -- -- -- -- Unqualified Opinion with Explanatory Notes --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Symbol Mini Chart % Chg
Ecopetrol
EC
+3.09%
Coinbase
COIN
+2.83%
Petroleo Brasileiro SA Petrobras
PBR
+2.45%
MicroStrategy
MSTR
+2.20%
NVIDIA
NVDA
+1.91%

Unlock the Full List